Merck said on Wednesday its experimental oral HIV medicine was found to be non-inferior to Gilead Sciences' top-selling drug ...

APPLIN: After nearly 20 years in HIV care, I’ve seen that HIV follows people through every season of life. When life is stable, patients stay in care and maintain suppression, but when challenges ...

Primary effectiveness was measured by the number of patients with HIV-1 RNA ≥50 copies/mL at Week 48, as well as the number of patients with a change in CD4 cell count, and the proportion of patients ...

Since the HIV epidemic began, the diagnosis of HIV has evolved from a death sentence to a chronic, but manageable condition by starting and staying on treatment. HIV treatment can help people live ...

Gilead Sciences, Inc. GILD announced that its investigational single-tablet regimen (STR) of bictegravir and lenacapavir for ...

Investing.com -- Gilead Sciences Inc (NASDAQ:GILD) stock rose 2.7% on Thursday after the company announced positive topline ...

HIV is a lifelong infection that affects many people. People with HIV take many different types of medicines to help control their condition and to prevent the infection from developing into AIDS.

A mathematical modeling study coordinated by UMC Utrecht has shown that sustained HIV remission (without rebound) or HIV eradication cure scenarios could consistently reduce new HIV infections among ...

The claim: New $40,000 twice yearly shot is 'AIDS cure' A Dec. 2 Instagram post (direct link, archive link) shows a syringe extracting fluid from a vial and claims a cure has been developed for a ...

Karl Neumann, RN, had seen too many people suffer while waiting for a life-saving organ to become available. One day, he vowed, he would donate one of his kidneys, shortening someone’s time on the ...

As the first COVID-19 vaccines are rolled out around the world, HIV/AIDS experts and advocates have sought to reassure those ...